IMRN – Immuron Limited ADR

Float Short %

1.05

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

0.58

EPS This/Next Y

Price

0.89

Target Price

Analyst Recom

Performance Q

-61.09

Relative Volume

0.08

Beta

0.83

Ticker: IMRN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	IMRN	1.52	N/A	N/A	0
2025-12-10	IMRN	1.11	N/A	N/A	0
2025-12-11	IMRN	1.08	N/A	N/A	0
2025-12-12	IMRN	1.02	N/A	N/A	0
2025-12-15	IMRN	0.9701	N/A	N/A	0
2025-12-16	IMRN	0.9486	N/A	N/A	0
2025-12-17	IMRN	0.9412	N/A	N/A	0
2025-12-18	IMRN	0.9441	N/A	N/A	0
2025-12-19	IMRN	0.9419	N/A	N/A	0
2025-12-22	IMRN	0.951	N/A	N/A	0
2025-12-23	IMRN	0.9101	N/A	N/A	0
2025-12-26	IMRN	0.9	N/A	N/A	0
2025-12-29	IMRN	0.8578	N/A	N/A	0
2025-12-30	IMRN	0.76	N/A	N/A	0
2025-12-31	IMRN	0.7686	N/A	N/A	0
2026-01-02	IMRN	0.7999	N/A	N/A	0
2026-01-05	IMRN	0.8345	N/A	N/A	0
2026-01-06	IMRN	0.83	N/A	N/A	0
2026-01-07	IMRN	0.88	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	IMRN	1.51	-	-	-
2025-12-10	IMRN	1.12	-	-	-
2025-12-11	IMRN	1.08	-	-	-
2025-12-12	IMRN	1.01	-	-	-0.02
2025-12-15	IMRN	0.97	-	-	-0.02
2025-12-16	IMRN	0.97	-	-	-0.02
2025-12-17	IMRN	0.95	-	-	-0.02
2025-12-18	IMRN	0.94	-	-	-0.02
2025-12-19	IMRN	0.94	-	-	-0.02
2025-12-22	IMRN	0.95	-	-	-0.02
2025-12-23	IMRN	0.91	-	-	-0.02
2025-12-26	IMRN	0.90	-	-	-0.02
2025-12-29	IMRN	0.85	-	-	-0.02
2025-12-30	IMRN	0.75	-	-	-0.02
2025-12-31	IMRN	0.77	-	-	-0.02
2026-01-02	IMRN	0.80	-	-	-0.02
2026-01-05	IMRN	0.84	-	-	-0.02
2026-01-06	IMRN	0.83	-	-	-0.02
2026-01-07	IMRN	0.89	-	-	-0.02
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	IMRN	0	-39.24	4.17
2025-12-10	IMRN	0	-39.24	2.53
2025-12-11	IMRN	0	-39.24	2.53
2025-12-12	IMRN	0	-39.24	2.53
2025-12-15	IMRN	0	29.77	2.53
2025-12-16	IMRN	0	29.77	2.53
2025-12-17	IMRN	0	29.77	2.53
2025-12-18	IMRN	0	29.77	2.53
2025-12-19	IMRN	0	29.77	2.53
2025-12-22	IMRN	0	25.75	2.53
2025-12-23	IMRN	0	25.75	2.53
2025-12-26	IMRN	0	25.75	1.05
2025-12-29	IMRN	0	25.75	1.05
2025-12-30	IMRN	0	25.75	1.05
2025-12-31	IMRN	0	25.75	1.05
2026-01-02	IMRN	0	25.75	1.05
2026-01-05	IMRN	0	25.75	1.05
2026-01-06	IMRN	0	25.75	1.05
2026-01-07	IMRN	0	25.75	1.05
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

25.75

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.3

Max Drawdown 5-Year %

-91

Target Price

P/E

Forward P/E

PEG

P/S

1.49

P/B

0.95

P/Free Cash Flow

EPS

-0.58

Average EPS Est. Cur. Y

-0.02

EPS Next Y. (Est.)

-0.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-71.37

Relative Volume

0.08

Return on Equity vs Sector %

-91.7

Return on Equity vs Industry %

-76.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

Immuron Limited

Sector: Healthcare

Industry: Biotechnology

Employees: 7

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

stock quote shares IMRN – Immuron Limited ADR Stock Price stock today

news today IMRN – Immuron Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMRN – Immuron Limited ADR yahoo finance google finance

stock history IMRN – Immuron Limited ADR invest stock market

stock prices IMRN premarket after hours

ticker IMRN fair value insiders trading

IMMP – Immutep Limited ADR

Float Short %

3.32

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

EPS Last/This Y

0.03

EPS This/Next Y

0.02

Price

3.02

Target Price

8.89

Analyst Recom

1.43

Performance Q

46.15

Relative Volume

0.4

Beta

1.76

Ticker: IMMP

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	IMMP	2.26	0.06	0.55	5974
2025-12-10	IMMP	2.49	0.06	0.14	6055
2025-12-11	IMMP	2.63	0.06	0.10	6071
2025-12-12	IMMP	2.57	0.06	0.00	6177
2025-12-15	IMMP	2.445	0.06	0.05	6164
2025-12-16	IMMP	2.49	0.06	0.10	6149
2025-12-17	IMMP	2.65	0.06	0.26	6159
2025-12-18	IMMP	2.62	0.06	0.05	6164
2025-12-19	IMMP	2.61	0.06	0.38	6168
2025-12-22	IMMP	2.79	0.07	0.98	4300
2025-12-23	IMMP	2.93	0.10	0.44	4364
2025-12-26	IMMP	3.13	0.10	0.94	4377
2025-12-29	IMMP	3.03	0.18	1.50	5073
2025-12-30	IMMP	2.88	0.18	0.09	5064
2025-12-31	IMMP	2.84	0.18	0.00	5067
2026-01-02	IMMP	2.97	0.18	0.00	5076
2026-01-05	IMMP	2.87	0.18	0.00	5115
2026-01-06	IMMP	2.95	0.18	0.06	5095
2026-01-07	IMMP	3.05	0.17	0.20	5201
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	IMMP	2.25	-	-40.8	-0.25
2025-12-10	IMMP	2.49	-	-52.9	-0.25
2025-12-11	IMMP	2.63	-	-29.0	-0.25
2025-12-12	IMMP	2.58	-	-26.9	-0.25
2025-12-15	IMMP	2.44	-	-21.8	-0.25
2025-12-16	IMMP	2.44	-	-23.7	-0.25
2025-12-17	IMMP	2.63	-	-29.0	-0.25
2025-12-18	IMMP	2.62	-	-59.9	-0.25
2025-12-19	IMMP	2.60	-	-58.8	-0.25
2025-12-22	IMMP	2.79	-	-69.6	-0.25
2025-12-23	IMMP	2.94	-	-77.0	-0.25
2025-12-26	IMMP	3.13	-	-86.7	-0.25
2025-12-29	IMMP	3.02	-	-80.7	-0.25
2025-12-30	IMMP	2.93	-	-60.5	-0.25
2025-12-31	IMMP	2.85	-	-57.1	-0.25
2026-01-02	IMMP	2.95	-	-61.5	-0.25
2026-01-05	IMMP	2.88	-	-58.4	-0.25
2026-01-06	IMMP	2.94	-	-72.7	-0.25
2026-01-07	IMMP	3.02	-	-76.7	-0.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	IMMP	0.00	-17.80	3.16
2025-12-10	IMMP	0.00	-17.80	3.09
2025-12-11	IMMP	0.00	-17.80	3.08
2025-12-12	IMMP	0.00	-17.80	3.08
2025-12-15	IMMP	0.00	-17.66	3.08
2025-12-16	IMMP	0.00	-17.66	3.08
2025-12-17	IMMP	0.00	-17.66	3.08
2025-12-18	IMMP	0.00	-17.66	3.08
2025-12-19	IMMP	0.00	-17.66	3.08
2025-12-22	IMMP	0.00	-17.08	3.08
2025-12-23	IMMP	0.00	-17.08	3.08
2025-12-26	IMMP	0.00	-17.08	3.32
2025-12-29	IMMP	0.00	-19.14	3.32
2025-12-30	IMMP	0.00	-19.14	3.32
2025-12-31	IMMP	0.00	-19.14	3.32
2026-01-02	IMMP	0.00	-19.14	3.32
2026-01-05	IMMP	0.00	4.27	3.32
2026-01-06	IMMP	0.00	4.27	3.32
2026-01-07	IMMP	0.00	4.27	3.32
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

4.27

Beta

1.76

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

44.5

Max Drawdown 5-Year %

-72.9

Target Price

8.89

P/E

Forward P/E

PEG

P/S

P/B

4.72

P/Free Cash Flow

EPS

-0.27

Average EPS Est. Cur. Y

-0.25

EPS Next Y. (Est.)

-0.23

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.4

Return on Equity vs Sector %

-69.8

Return on Equity vs Industry %

-54.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-76.7

Immutep Limited

Sector: Healthcare

Industry: Biotechnology

Employees:

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

stock quote shares IMMP – Immutep Limited ADR Stock Price stock today

news today IMMP – Immutep Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMMP – Immutep Limited ADR yahoo finance google finance

stock history IMMP – Immutep Limited ADR invest stock market

stock prices IMMP premarket after hours

ticker IMMP fair value insiders trading

GENE – Genetic Technologies Ltd. ADR

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=GENE #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=GENE &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.76

Target Price

6.87

Analyst Recom

Performance Q

-14.99

Relative Volume

Beta

1.11

Ticker: GENE

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	GENE	0.765	N/A	N/A	0
2025-12-10	GENE	0.765	N/A	N/A	0
2025-12-11	GENE	0.765	N/A	N/A	0
2025-12-12	GENE	0.765	N/A	N/A	0
2025-12-15	GENE	0.765	N/A	N/A	0
2025-12-16	GENE	0.765	N/A	N/A	0
2025-12-17	GENE	0.765	N/A	N/A	0
2025-12-18	GENE	0.765	N/A	N/A	0
2025-12-19	GENE	0.765	N/A	N/A	0
2025-12-22	GENE	0.765	N/A	N/A	0
2025-12-23	GENE	0.765	N/A	N/A	0
2025-12-26	GENE	0.765	N/A	N/A	0
2025-12-29	GENE	0.765	N/A	N/A	0
2025-12-30	GENE	0.765	N/A	N/A	0
2025-12-31	GENE	0.765	N/A	N/A	0
2026-01-02	GENE	0.765	N/A	N/A	0
2026-01-05	GENE	0.765	N/A	N/A	0
2026-01-06	GENE	0.765	N/A	N/A	0
2026-01-07	GENE	0.765	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=GENE 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

1.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-97.7

Target Price

6.87

P/E

Forward P/E

PEG

P/S

1.24

P/B

2.89

P/Free Cash Flow

EPS

-1.83

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-156.76

Relative Volume

Return on Equity vs Sector %

-680.2

Return on Equity vs Industry %

-667.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=GENE 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=GENE 589 450 ]

stock quote shares GENE – Genetic Technologies Ltd. ADR Stock Price stock today

news today GENE – Genetic Technologies Ltd. ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch GENE – Genetic Technologies Ltd. ADR yahoo finance google finance

stock history GENE – Genetic Technologies Ltd. ADR invest stock market

stock prices GENE premarket after hours

ticker GENE fair value insiders trading

WDS – Woodside Energy Group Ltd

Float Short %

0.11

Margin Of Safety %

Put/Call OI Ratio

0.28

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

15.35

Target Price

17.64

Analyst Recom

2.27

Performance Q

0.85

Relative Volume

1.59

Beta

0.48

Ticker: WDS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	WDS	16.49	0.18	0.00	6882
2025-12-10	WDS	16.49	0.18	0.00	6887
2025-12-11	WDS	16.4	0.18	0.00	6880
2025-12-12	WDS	16.22	0.18	0.38	6881
2025-12-15	WDS	16.09	0.18	0.00	6888
2025-12-16	WDS	15.65	0.18	0.71	6936
2025-12-17	WDS	15.43	0.18	1.27	6958
2025-12-18	WDS	14.6	0.18	4.75	6959
2025-12-19	WDS	14.91	0.26	2.56	7656
2025-12-22	WDS	15.23	0.22	2.18	6433
2025-12-23	WDS	15.48	0.25	7.69	6723
2025-12-26	WDS	15.36	0.28	0.00	6888
2025-12-29	WDS	15.52	0.28	0.02	6910
2025-12-30	WDS	15.62	0.28	0.03	6982
2025-12-31	WDS	15.59	0.28	1.00	7026
2026-01-02	WDS	15.98	0.28	0.02	7045
2026-01-05	WDS	15.69	0.28	1.00	7046
2026-01-06	WDS	15.61	0.28	0.18	7054
2026-01-07	WDS	15.35	0.28	0.17	7066
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	WDS	16.48	-	-	-
2025-12-10	WDS	16.49	-	-	-
2025-12-11	WDS	16.39	-	-	-
2025-12-12	WDS	16.22	-	-	-
2025-12-15	WDS	16.09	-	-	-
2025-12-16	WDS	16.09	-	-	-
2025-12-17	WDS	15.43	-	-	-
2025-12-18	WDS	14.60	-	-	-
2025-12-19	WDS	14.91	-	-	-
2025-12-22	WDS	15.20	-	-	-
2025-12-23	WDS	15.47	-	-	-
2025-12-26	WDS	15.36	-	-	-
2025-12-29	WDS	15.52	-	-	-
2025-12-30	WDS	15.63	-	-	-
2025-12-31	WDS	15.59	-	-	-
2026-01-02	WDS	15.99	-	-	-
2026-01-05	WDS	15.68	-	-	-
2026-01-06	WDS	15.61	-	-	-
2026-01-07	WDS	15.35	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	WDS	0	-0.29	0.08
2025-12-10	WDS	0	-0.29	0.10
2025-12-11	WDS	0	-0.29	0.10
2025-12-12	WDS	0	-0.29	0.10
2025-12-15	WDS	0	-0.22	0.10
2025-12-16	WDS	0	-0.22	0.10
2025-12-17	WDS	0	-0.22	0.10
2025-12-18	WDS	0	-0.22	0.10
2025-12-19	WDS	0	-0.22	0.10
2025-12-22	WDS	0	-0.27	0.10
2025-12-23	WDS	0	-0.27	0.10
2025-12-26	WDS	0	-0.27	0.11
2025-12-29	WDS	0	-0.30	0.11
2025-12-30	WDS	0	-0.30	0.11
2025-12-31	WDS	0	-0.30	0.11
2026-01-02	WDS	0	-0.30	0.11
2026-01-05	WDS	0	-0.25	0.11
2026-01-06	WDS	0	-0.25	0.11
2026-01-07	WDS	0	-0.25	0.11
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.25

Beta

0.48

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

3065

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-48.8

Target Price

17.64

P/E

9.96

Forward P/E

19.81

PEG

P/S

P/B

0.82

P/Free Cash Flow

EPS

1.54

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.25

Relative Volume

1.59

Return on Equity vs Sector %

-1.9

Return on Equity vs Industry %

-4.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Woodside Energy Group Limited

Sector: Energy

Industry: Oil & Gas E&P

Employees: 4718

Woodside Energy Group Ltd engages in the exploration, evaluation, development, production, marketing, and sale of hydrocarbons in the Asia Pacific, Africa, the Americas, and the Europe. The company produces liquefied natural gas, pipeline gas, crude oil and condensate, and natural gas liquids. It holds interests in the Pluto LNG, North West Shelf, Wheatstone and Julimar-Brunello, Bass Strait, Ngujima-Yin FPSO, Okha FPSO, Pyrenees FPSO, Macedon, Shenzi, Mad dog, Greater Angostura, as well as Scarborough, Sangomar, Trion, Calypso, Browse, Liard, Ruby, Sangomar, Atlantis, Woodside Solar opportunity, and Sunrise and Troubadour. The company is also involved in the development of new energy products and lower-carbon services. The company was formerly known as Woodside Petroleum Ltd and changed its name to Woodside Energy Group Ltd in May 2022. Woodside Energy Group Ltd was founded in 1954 and is headquartered in Perth, Australia.

stock quote shares WDS – Woodside Energy Group Ltd Stock Price stock today

news today WDS – Woodside Energy Group Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch WDS – Woodside Energy Group Ltd yahoo finance google finance

stock history WDS – Woodside Energy Group Ltd invest stock market

stock prices WDS premarket after hours

ticker WDS fair value insiders trading

BHP – BHP Group Limited

Float Short %

0.6

Margin Of Safety %

Put/Call OI Ratio

0.88

EPS Next Q Diff

EPS Last/This Y

0.92

EPS This/Next Y

-0.12

Price

63.85

Target Price

47.91

Analyst Recom

3.14

Performance Q

15.69

Relative Volume

0.82

Beta

0.82

Ticker: BHP

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	BHP	59.01	0.92	1.10	168207
2025-12-10	BHP	60.53	0.93	0.69	169119
2025-12-11	BHP	60.94	0.92	0.54	169902
2025-12-12	BHP	59.64	0.92	2.38	171921
2025-12-15	BHP	59.19	0.96	0.45	175855
2025-12-16	BHP	58.62	0.95	1.85	176823
2025-12-17	BHP	59.03	0.95	0.23	176926
2025-12-18	BHP	59.29	0.95	0.28	177281
2025-12-19	BHP	59.33	0.95	1.99	177184
2025-12-22	BHP	60.78	0.88	0.51	159111
2025-12-23	BHP	61.07	0.88	0.42	160403
2025-12-26	BHP	61.89	0.88	0.34	161700
2025-12-29	BHP	60.4	0.88	1.54	162924
2025-12-30	BHP	60.92	0.89	0.37	163797
2025-12-31	BHP	60.35	0.89	1.42	165942
2026-01-02	BHP	61.76	0.89	0.60	166237
2026-01-05	BHP	63.17	0.88	0.57	173372
2026-01-06	BHP	64.8	0.88	1.04	174190
2026-01-07	BHP	63.87	0.88	0.15	182928
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	BHP	59.01	-	2065.5	4.26
2025-12-10	BHP	59.01	-	2866.9	4.38
2025-12-11	BHP	60.92	-	2548.1	4.38
2025-12-12	BHP	59.65	-	1744.1	4.38
2025-12-15	BHP	59.19	-	1409.9	4.38
2025-12-16	BHP	59.19	-	1853.8	4.38
2025-12-17	BHP	59.03	-	2024.8	4.38
2025-12-18	BHP	59.27	-	2064.4	4.38
2025-12-19	BHP	59.33	-	1961.2	4.38
2025-12-22	BHP	60.72	-	2649.6	4.38
2025-12-23	BHP	61.11	-	2449.6	4.38
2025-12-26	BHP	61.90	-	516.7	4.38
2025-12-29	BHP	60.40	-	54.9	4.38
2025-12-30	BHP	60.92	-	505.7	4.38
2025-12-31	BHP	60.35	-	528.8	4.38
2026-01-02	BHP	61.76	-	807.8	4.48
2026-01-05	BHP	63.17	-	1186.5	4.48
2026-01-06	BHP	64.82	-	1374.4	4.48
2026-01-07	BHP	63.85	-	699.3	4.48
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	BHP	0	26.12	0.69
2025-12-10	BHP	0	26.12	0.56
2025-12-11	BHP	0	26.12	0.56
2025-12-12	BHP	0	26.12	0.56
2025-12-15	BHP	0	3.09	0.56
2025-12-16	BHP	0	3.09	0.56
2025-12-17	BHP	0	3.09	0.56
2025-12-18	BHP	0	3.09	0.56
2025-12-19	BHP	0	3.09	0.56
2025-12-22	BHP	0	2.67	0.56
2025-12-23	BHP	0	2.67	0.56
2025-12-26	BHP	0	2.67	0.60
2025-12-29	BHP	0	-1.32	0.60
2025-12-30	BHP	0	-1.32	0.60
2025-12-31	BHP	0	-1.32	0.60
2026-01-02	BHP	0	-1.32	0.60
2026-01-05	BHP	0	-0.34	0.60
2026-01-06	BHP	0	-0.34	0.60
2026-01-07	BHP	0	-0.34	0.60
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.34

Beta

0.82

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

65.13

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

12.8

Max Drawdown 5-Year %

-37.2

Target Price

47.91

P/E

17.99

Forward P/E

14.87

PEG

7.08

P/S

3.16

P/B

3.4

P/Free Cash Flow

17.44

EPS

3.55

Average EPS Est. Cur. Y

4.48

EPS Next Y. (Est.)

4.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.59

Relative Volume

0.82

Return on Equity vs Sector %

4.6

Return on Equity vs Industry %

4.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.31

EBIT Estimation

699.3

BHP Group Limited

Sector: Basic Materials

Industry: Other Industrial Metals & Mining

Employees: 39369

BHP Group Limited operates as a resources company in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and internationally. The company operates through Copper, Iron Ore, and Coal segments. It also engages in the mining of copper, uranium, gold, zinc, lead, molybdenum, silver, iron ore, cobalt, and metallurgical and energy coal. In addition, the company is involved in the mining, smelting, and refining of nickel, as well as potash development activities. Further, it provides towing, freight, marketing and trading, marketing support, finance, administrative, and other services. BHP Group Limited was founded in 1851 and is headquartered in Melbourne, Australia.

stock quote shares BHP – BHP Group Limited Stock Price stock today

news today BHP – BHP Group Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch BHP – BHP Group Limited yahoo finance google finance

stock history BHP – BHP Group Limited invest stock market

stock prices BHP premarket after hours

ticker BHP fair value insiders trading

TEAM – Atlassian Corporation Plc

Float Short %

3.11

Margin Of Safety %

-20

Put/Call OI Ratio

0.85

EPS Next Q Diff

EPS Last/This Y

1.2

EPS This/Next Y

0.77

Price

160.89

Target Price

244.11

Analyst Recom

1.51

Performance Q

7.16

Relative Volume

Beta

0.89

Ticker: TEAM

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	TEAM	161.4	0.75	0.37	99284
2025-12-10	TEAM	161.71	0.75	0.06	101674
2025-12-11	TEAM	163.26	0.75	1.23	101860
2025-12-12	TEAM	162.03	0.75	0.51	102652
2025-12-15	TEAM	158.77	0.75	0.97	99109
2025-12-16	TEAM	159.79	0.76	1.03	98867
2025-12-17	TEAM	161.99	0.76	0.53	100059
2025-12-18	TEAM	164.6	0.74	0.82	100242
2025-12-19	TEAM	161.02	0.73	0.92	100980
2025-12-22	TEAM	164.47	0.86	0.82	76929
2025-12-23	TEAM	162.4	0.86	0.71	77805
2025-12-26	TEAM	163.2	0.85	0.58	78736
2025-12-29	TEAM	164.26	0.86	1.15	77183
2025-12-30	TEAM	162.99	0.87	0.65	77971
2025-12-31	TEAM	162.18	0.87	1.66	78386
2026-01-02	TEAM	154.76	0.85	1.38	77927
2026-01-05	TEAM	154.28	0.87	0.96	77131
2026-01-06	TEAM	158.38	0.87	0.61	78761
2026-01-07	TEAM	160.88	0.85	0.79	80695
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	TEAM	161.41	18.6	856.4	4.87
2025-12-10	TEAM	161.75	18.6	854.7	4.87
2025-12-11	TEAM	163.29	18.6	860.7	4.87
2025-12-12	TEAM	162.01	18.6	847.0	4.87
2025-12-15	TEAM	159.17	18.6	839.1	4.87
2025-12-16	TEAM	159.17	18.6	854.9	4.87
2025-12-17	TEAM	162.04	18.6	865.4	4.87
2025-12-18	TEAM	164.92	19.0	867.4	4.87
2025-12-19	TEAM	161.02	19.0	834.1	4.87
2025-12-22	TEAM	163.95	19.0	867.4	4.87
2025-12-23	TEAM	162.49	19.0	843.4	4.87
2025-12-26	TEAM	163.16	19.2	863.1	4.88
2025-12-29	TEAM	164.00	19.2	857.2	4.88
2025-12-30	TEAM	162.97	19.2	848.2	4.88
2025-12-31	TEAM	162.18	19.2	849.5	4.88
2026-01-02	TEAM	154.84	19.2	817.6	4.88
2026-01-05	TEAM	153.91	19.2	848.8	4.88
2026-01-06	TEAM	158.45	19.2	876.6	4.88
2026-01-07	TEAM	160.89	19.2	865.7	4.88
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	TEAM	-1.98	0.21	3.89
2025-12-10	TEAM	-2.00	0.21	2.85
2025-12-11	TEAM	-2.00	0.21	2.85
2025-12-12	TEAM	-2.00	0.21	2.85
2025-12-15	TEAM	-2.00	0.22	2.85
2025-12-16	TEAM	-2.00	0.22	2.85
2025-12-17	TEAM	-2.00	0.22	2.85
2025-12-18	TEAM	-2.00	0.22	2.85
2025-12-19	TEAM	-2.00	0.22	2.85
2025-12-22	TEAM	-2.00	-0.23	2.84
2025-12-23	TEAM	-2.00	-0.23	2.84
2025-12-26	TEAM	-2.00	-0.23	3.11
2025-12-29	TEAM	-1.97	-0.24	3.11
2025-12-30	TEAM	-2.02	-0.24	3.11
2025-12-31	TEAM	-2.02	-0.24	3.11
2026-01-02	TEAM	-2.02	-0.24	3.11
2026-01-05	TEAM	-1.97	-0.23	3.11
2026-01-06	TEAM	-1.99	-0.23	3.11
2026-01-07	TEAM	-2.02	-0.23	3.11
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

1.14

Avg. EPS Est. Next Quarter

1.34

Insider Transactions

-2.02

Institutional Transactions

-0.23

Beta

0.89

Average Sales Estimate Current Quarter

1544

Average Sales Estimate Next Quarter

1650

Fair Value

128.06

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

66.7

Max Drawdown 5-Year %

-74.6

Target Price

244.11

P/E

Forward P/E

28.51

PEG

1.27

P/S

7.78

P/B

30.72

P/Free Cash Flow

28.29

EPS

-0.7

Average EPS Est. Cur. Y

4.88

EPS Next Y. (Est.)

5.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.38

Relative Volume

Return on Equity vs Sector %

-65.5

Return on Equity vs Industry %

-34

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

865.7

Atlassian Corporation

Sector: Technology

Industry: Software - Application

Employees: 14089

Atlassian Corporation provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide. Its product portfolio includes Jira, a project management platform for planning, tracking, and managing work; Confluence, a connected workspace to create, organize, and share team knowledge, documents, and collaboration content; Loom, an asynchronous video communication tool to record and share videos; Jira Service Management, an intuitive service management solution for IT, HR, and other teams; and Rovo, an AI offering that assists teams with its Search, Chat and Agent capabilities. The company also offers Bitbucket, a git-based source code management platform for professional development teams; Compass, a developer portal that provides a unified view of engineering components; Jira Product Discovery, a tool to capture, prioritize, and roadmap product ideas; Jira Align, an enterprise agility solution that connects business and technology teams to align strategy with execution; Focus, a strategy hub for leadership teams; and Talent, a workforce planning app. In addition, it provides Trello, an AI-powered personal productivity tool; and Guard, an app for detecting and responding to security threats. The company was founded in 2002 and is headquartered in Sydney, Australia.

stock quote shares TEAM – Atlassian Corporation Plc Stock Price stock today

news today TEAM – Atlassian Corporation Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch TEAM – Atlassian Corporation Plc yahoo finance google finance

stock history TEAM – Atlassian Corporation Plc invest stock market

stock prices TEAM premarket after hours

ticker TEAM fair value insiders trading

IMRN – Immuron Limited ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: IMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

IMMP – Immutep Limited ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: IMMP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y